Related Experiment Videos
[Thalassemia major (with a case report of a 6-month-old patient)]
Insights
This study reviews thalassemia pathophysiology and presents a case of thalassemia major in an infant. Treatment involved blood transfusions and desferrioxamine to manage anemia and iron overload.
Area of Science:
- Hematology
- Pediatrics
- Genetics
Background:
- Thalassemia is a group of inherited blood disorders characterized by reduced or absent synthesis of globin chains.
- Thalassemia major is the most severe form, requiring lifelong treatment.
Observation:
- A case of thalassemia major in a 6-month-old infant from continental Croatia is presented.
- The infant exhibited symptoms consistent with severe anemia.
Findings:
- Therapy included frequent blood transfusions to maintain adequate hemoglobin levels for normal development.
- Desferrioxamine administration facilitated iron excretion, reducing serum iron concentration.
Implications:
- This case highlights the importance of timely diagnosis and management of thalassemia major.
- Effective treatment strategies, including transfusions and iron chelation, are crucial for improving patient outcomes.
Abstract:
This article describes recent views about patophysiology of thalassemia, and deals with a case of thalassemia major in a 6-month infant from the continental part of Croatia. Based on literature data, therapy included frequent transfusions of blood so as to correct anaemia to the level enabling the child to develop and interact with his environment as normally as possible. Administration of desferioxamine promoted excretion of iron in urine and decreased its concentration in serum.